Weekly Buzz: Tech stocks hit high scores on ominous day
West Pharmaceutical Services to Buy Back Up To 550,000 Shares
West Pharma Is Maintained at Buy by B of A Securities
Market Mixed on Friday the 13th | Livestock
Express News | West Pharmaceutical Services Inc : BofA Global Research Raises Price Objective to $355 From $350
West Pharma Initiated at Peer Perform by Wolfe Research
BofA Securities Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $355
Wolfe Research Initiates West Pharmaceutical Services(WST.US) With Hold Rating
Thursday Ends in Index Declines | Wall Street Today
West Pharmaceutical Services Shares Are Trading Higher After UBS Upgraded the Stock From Neutral to Buy and Raised Its Price Target From $350 to $390.
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
West Pharma Raised to Buy From Neutral by UBS
West Pharmaceutical Servs Analyst Ratings
UBS Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $390
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Express News | West Pharmaceutical Services Inc - Board Now Has 12 Directors
Express News | West Elects New Director to the Board
Press Release: West Elects New Director to the Board
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock